Global Sexual Dysfunction Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.
Scope of the Report:
This report studies the Sexual Dysfunction Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sexual Dysfunction Drugs market by product type and applications/end industries.
The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.
The demand for sexual dysfunction drugs is increasing due to the rising prevalence of chronic diseases such as prostate cancer, diabetes mellitus, and CVD. The market will continue to grow in the region in the forthcoming years due to the rise in unhealthy lifestyle habits and the increased risk of developing sexual dysfunctions among the population.
The global Sexual Dysfunction Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sexual Dysfunction Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
Scope of the Report:
This report studies the Sexual Dysfunction Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sexual Dysfunction Drugs market by product type and applications/end industries.
The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.
The demand for sexual dysfunction drugs is increasing due to the rising prevalence of chronic diseases such as prostate cancer, diabetes mellitus, and CVD. The market will continue to grow in the region in the forthcoming years due to the rise in unhealthy lifestyle habits and the increased risk of developing sexual dysfunctions among the population.
The global Sexual Dysfunction Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sexual Dysfunction Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Pfizer
- GlaxoSmithKline
- Merck
- Eli Lilly
- AbbVie
- Bayer
- Teva Pharmaceutical Industries
- Takeda
- Apricus Biosciences
- Emotional Brain
- Ivix LLX
- Leadiant Biosciences
- NexMed
- S1 Biopharma
- Vietstar Biomedical Research
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
- Oral Therapy
- Intracavernosal Therapy
- Hormonal Therapy
- Transurethral Therapy
- Male
- Female
1 SEXUAL DYSFUNCTION DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Sexual Dysfunction Drugs
1.2 Classification of Sexual Dysfunction Drugs by Types
1.2.1 Global Sexual Dysfunction Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Sexual Dysfunction Drugs Revenue Market Share by Types in 2017
1.2.3 Oral Therapy
1.2.4 Intracavernosal Therapy
1.2.5 Hormonal Therapy
1.2.6 Transurethral Therapy
1.3 Global Sexual Dysfunction Drugs Market by Application
1.3.1 Global Sexual Dysfunction Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Male
1.3.3 Female
1.4 Global Sexual Dysfunction Drugs Market by Regions
1.4.1 Global Sexual Dysfunction Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Sexual Dysfunction Drugs (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Sexual Dysfunction Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Sexual Dysfunction Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Sexual Dysfunction Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Sexual Dysfunction Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 AbbVie
2.5.1 Business Overview
2.5.2 Sexual Dysfunction Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AbbVie Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Sexual Dysfunction Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva Pharmaceutical Industries
2.7.1 Business Overview
2.7.2 Sexual Dysfunction Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda
2.8.1 Business Overview
2.8.2 Sexual Dysfunction Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Apricus Biosciences
2.9.1 Business Overview
2.9.2 Sexual Dysfunction Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Apricus Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Emotional Brain
2.10.1 Business Overview
2.10.2 Sexual Dysfunction Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Emotional Brain Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ivix LLX
2.11.1 Business Overview
2.11.2 Sexual Dysfunction Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ivix LLX Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.12 Leadiant Biosciences
2.12.1 Business Overview
2.12.2 Sexual Dysfunction Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.13 NexMed
2.13.1 Business Overview
2.13.2 Sexual Dysfunction Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 NexMed Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.14 S1 Biopharma
2.14.1 Business Overview
2.14.2 Sexual Dysfunction Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 S1 Biopharma Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.15 Vietstar Biomedical Research
2.15.1 Business Overview
2.15.2 Sexual Dysfunction Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET COMPETITION, BY PLAYERS
3.1 Global Sexual Dysfunction Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Sexual Dysfunction Drugs Players Market Share
3.2.2 Top 10 Sexual Dysfunction Drugs Players Market Share
3.3 Market Competition Trend
4 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SIZE BY REGIONS
4.1 Global Sexual Dysfunction Drugs Revenue and Market Share by Regions
4.2 North America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA SEXUAL DYSFUNCTION DRUGS REVENUE BY COUNTRIES
5.1 North America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
5.2 USA Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6 EUROPE SEXUAL DYSFUNCTION DRUGS REVENUE BY COUNTRIES
6.1 Europe Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
6.2 Germany Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.4 France Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC SEXUAL DYSFUNCTION DRUGS REVENUE BY COUNTRIES
7.1 Asia-Pacific Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
7.2 China Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.5 India Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA SEXUAL DYSFUNCTION DRUGS REVENUE BY COUNTRIES
8.1 South America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
8.2 Brazil Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE SEXUAL DYSFUNCTION DRUGS BY COUNTRIES
9.1 Middle East and Africa Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
10 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SEGMENT BY TYPE
10.1 Global Sexual Dysfunction Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Sexual Dysfunction Drugs Market Forecast by Type (2018-2023)
10.3 Oral Therapy Revenue Growth Rate (2013-2023)
10.4 Intracavernosal Therapy Revenue Growth Rate (2013-2023)
10.5 Hormonal Therapy Revenue Growth Rate (2013-2023)
10.6 Transurethral Therapy Revenue Growth Rate (2013-2023)
11 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Sexual Dysfunction Drugs Revenue Market Share by Application (2013-2018)
11.2 Sexual Dysfunction Drugs Market Forecast by Application (2018-2023)
11.3 Male Revenue Growth (2013-2018)
11.4 Female Revenue Growth (2013-2018)
12 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SIZE FORECAST (2018-2023)
12.1 Global Sexual Dysfunction Drugs Market Size Forecast (2018-2023)
12.2 Global Sexual Dysfunction Drugs Market Forecast by Regions (2018-2023)
12.3 North America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.6 South America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Sexual Dysfunction Drugs
1.2 Classification of Sexual Dysfunction Drugs by Types
1.2.1 Global Sexual Dysfunction Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Sexual Dysfunction Drugs Revenue Market Share by Types in 2017
1.2.3 Oral Therapy
1.2.4 Intracavernosal Therapy
1.2.5 Hormonal Therapy
1.2.6 Transurethral Therapy
1.3 Global Sexual Dysfunction Drugs Market by Application
1.3.1 Global Sexual Dysfunction Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Male
1.3.3 Female
1.4 Global Sexual Dysfunction Drugs Market by Regions
1.4.1 Global Sexual Dysfunction Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Sexual Dysfunction Drugs (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Sexual Dysfunction Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Sexual Dysfunction Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Sexual Dysfunction Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Sexual Dysfunction Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 AbbVie
2.5.1 Business Overview
2.5.2 Sexual Dysfunction Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AbbVie Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Sexual Dysfunction Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva Pharmaceutical Industries
2.7.1 Business Overview
2.7.2 Sexual Dysfunction Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda
2.8.1 Business Overview
2.8.2 Sexual Dysfunction Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Apricus Biosciences
2.9.1 Business Overview
2.9.2 Sexual Dysfunction Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Apricus Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Emotional Brain
2.10.1 Business Overview
2.10.2 Sexual Dysfunction Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Emotional Brain Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ivix LLX
2.11.1 Business Overview
2.11.2 Sexual Dysfunction Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ivix LLX Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.12 Leadiant Biosciences
2.12.1 Business Overview
2.12.2 Sexual Dysfunction Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.13 NexMed
2.13.1 Business Overview
2.13.2 Sexual Dysfunction Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 NexMed Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.14 S1 Biopharma
2.14.1 Business Overview
2.14.2 Sexual Dysfunction Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 S1 Biopharma Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.15 Vietstar Biomedical Research
2.15.1 Business Overview
2.15.2 Sexual Dysfunction Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET COMPETITION, BY PLAYERS
3.1 Global Sexual Dysfunction Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Sexual Dysfunction Drugs Players Market Share
3.2.2 Top 10 Sexual Dysfunction Drugs Players Market Share
3.3 Market Competition Trend
4 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SIZE BY REGIONS
4.1 Global Sexual Dysfunction Drugs Revenue and Market Share by Regions
4.2 North America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA SEXUAL DYSFUNCTION DRUGS REVENUE BY COUNTRIES
5.1 North America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
5.2 USA Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6 EUROPE SEXUAL DYSFUNCTION DRUGS REVENUE BY COUNTRIES
6.1 Europe Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
6.2 Germany Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.4 France Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC SEXUAL DYSFUNCTION DRUGS REVENUE BY COUNTRIES
7.1 Asia-Pacific Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
7.2 China Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.5 India Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA SEXUAL DYSFUNCTION DRUGS REVENUE BY COUNTRIES
8.1 South America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
8.2 Brazil Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE SEXUAL DYSFUNCTION DRUGS BY COUNTRIES
9.1 Middle East and Africa Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
10 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SEGMENT BY TYPE
10.1 Global Sexual Dysfunction Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Sexual Dysfunction Drugs Market Forecast by Type (2018-2023)
10.3 Oral Therapy Revenue Growth Rate (2013-2023)
10.4 Intracavernosal Therapy Revenue Growth Rate (2013-2023)
10.5 Hormonal Therapy Revenue Growth Rate (2013-2023)
10.6 Transurethral Therapy Revenue Growth Rate (2013-2023)
11 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Sexual Dysfunction Drugs Revenue Market Share by Application (2013-2018)
11.2 Sexual Dysfunction Drugs Market Forecast by Application (2018-2023)
11.3 Male Revenue Growth (2013-2018)
11.4 Female Revenue Growth (2013-2018)
12 GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SIZE FORECAST (2018-2023)
12.1 Global Sexual Dysfunction Drugs Market Size Forecast (2018-2023)
12.2 Global Sexual Dysfunction Drugs Market Forecast by Regions (2018-2023)
12.3 North America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.6 South America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Sexual Dysfunction Drugs Picture
Table Product Specifications of Sexual Dysfunction Drugs
Table Global Sexual Dysfunction Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Sexual Dysfunction Drugs Revenue Market Share by Types in 2017
Figure Oral Therapy Picture
Figure Intracavernosal Therapy Picture
Figure Hormonal Therapy Picture
Figure Transurethral Therapy Picture
Table Global Sexual Dysfunction Drugs Revenue (Million USD) by Application (2013-2023)
Figure Sexual Dysfunction Drugs Revenue Market Share by Applications in 2017
Figure Male Picture
Figure Female Picture
Table Global Market Sexual Dysfunction Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Sexual Dysfunction Drugs Type and Applications
Table Pfizer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Sexual Dysfunction Drugs Type and Applications
Table GlaxoSmithKline Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Sexual Dysfunction Drugs Type and Applications
Table Merck Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Sexual Dysfunction Drugs Type and Applications
Table Eli Lilly Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Sexual Dysfunction Drugs Type and Applications
Table AbbVie Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Sexual Dysfunction Drugs Type and Applications
Table Bayer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Sexual Dysfunction Drugs Type and Applications
Table Teva Pharmaceutical Industries Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Sexual Dysfunction Drugs Type and Applications
Table Takeda Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Apricus Biosciences Basic Information, Manufacturing Base and Competitors
Table Apricus Biosciences Sexual Dysfunction Drugs Type and Applications
Table Apricus Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Emotional Brain Basic Information, Manufacturing Base and Competitors
Table Emotional Brain Sexual Dysfunction Drugs Type and Applications
Table Emotional Brain Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Ivix LLX Basic Information, Manufacturing Base and Competitors
Table Ivix LLX Sexual Dysfunction Drugs Type and Applications
Table Ivix LLX Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Leadiant Biosciences Basic Information, Manufacturing Base and Competitors
Table Leadiant Biosciences Sexual Dysfunction Drugs Type and Applications
Table Leadiant Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table NexMed Basic Information, Manufacturing Base and Competitors
Table NexMed Sexual Dysfunction Drugs Type and Applications
Table NexMed Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table S1 Biopharma Basic Information, Manufacturing Base and Competitors
Table S1 Biopharma Sexual Dysfunction Drugs Type and Applications
Table S1 Biopharma Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Vietstar Biomedical Research Basic Information, Manufacturing Base and Competitors
Table Vietstar Biomedical Research Sexual Dysfunction Drugs Type and Applications
Table Vietstar Biomedical Research Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Sexual Dysfunction Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue Share by Players (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Players in 2016
Figure Global Sexual Dysfunction Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Sexual Dysfunction Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Sexual Dysfunction Drugs Revenue Market Share in 2017
Figure Global Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Market Share by Regions in 2017
Figure North America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure South America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table North America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
Table North America Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure USA Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table Europe Sexual Dysfunction Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure Germany Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure UK Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure France Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Sexual Dysfunction Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure China Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure India Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table South America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
Table South America Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure Brazil Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Sexual Dysfunction Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue Share by Type (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Type (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Type in 2017
Table Global Sexual Dysfunction Drugs Revenue Forecast by Type (2018-2023)
Figure Global Sexual Dysfunction Drugs Market Share Forecast by Type (2018-2023)
Figure Global Oral Therapy Revenue Growth Rate (2013-2018)
Figure Global Intracavernosal Therapy Revenue Growth Rate (2013-2018)
Figure Global Hormonal Therapy Revenue Growth Rate (2013-2018)
Figure Global Transurethral Therapy Revenue Growth Rate (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue by Application (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue Share by Application (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Application (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Application in 2017
Table Global Sexual Dysfunction Drugs Revenue Forecast by Application (2018-2023)
Figure Global Sexual Dysfunction Drugs Market Share Forecast by Application (2018-2023)
Figure Global Male Revenue Growth Rate (2013-2018)
Figure Global Female Revenue Growth Rate (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Sexual Dysfunction Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Sexual Dysfunction Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
Figure Europe Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
Figure South America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
Figure Sexual Dysfunction Drugs Picture
Table Product Specifications of Sexual Dysfunction Drugs
Table Global Sexual Dysfunction Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Sexual Dysfunction Drugs Revenue Market Share by Types in 2017
Figure Oral Therapy Picture
Figure Intracavernosal Therapy Picture
Figure Hormonal Therapy Picture
Figure Transurethral Therapy Picture
Table Global Sexual Dysfunction Drugs Revenue (Million USD) by Application (2013-2023)
Figure Sexual Dysfunction Drugs Revenue Market Share by Applications in 2017
Figure Male Picture
Figure Female Picture
Table Global Market Sexual Dysfunction Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Sexual Dysfunction Drugs Type and Applications
Table Pfizer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Sexual Dysfunction Drugs Type and Applications
Table GlaxoSmithKline Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Sexual Dysfunction Drugs Type and Applications
Table Merck Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Sexual Dysfunction Drugs Type and Applications
Table Eli Lilly Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Sexual Dysfunction Drugs Type and Applications
Table AbbVie Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Sexual Dysfunction Drugs Type and Applications
Table Bayer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Sexual Dysfunction Drugs Type and Applications
Table Teva Pharmaceutical Industries Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Sexual Dysfunction Drugs Type and Applications
Table Takeda Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Apricus Biosciences Basic Information, Manufacturing Base and Competitors
Table Apricus Biosciences Sexual Dysfunction Drugs Type and Applications
Table Apricus Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Emotional Brain Basic Information, Manufacturing Base and Competitors
Table Emotional Brain Sexual Dysfunction Drugs Type and Applications
Table Emotional Brain Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Ivix LLX Basic Information, Manufacturing Base and Competitors
Table Ivix LLX Sexual Dysfunction Drugs Type and Applications
Table Ivix LLX Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Leadiant Biosciences Basic Information, Manufacturing Base and Competitors
Table Leadiant Biosciences Sexual Dysfunction Drugs Type and Applications
Table Leadiant Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table NexMed Basic Information, Manufacturing Base and Competitors
Table NexMed Sexual Dysfunction Drugs Type and Applications
Table NexMed Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table S1 Biopharma Basic Information, Manufacturing Base and Competitors
Table S1 Biopharma Sexual Dysfunction Drugs Type and Applications
Table S1 Biopharma Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Vietstar Biomedical Research Basic Information, Manufacturing Base and Competitors
Table Vietstar Biomedical Research Sexual Dysfunction Drugs Type and Applications
Table Vietstar Biomedical Research Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Sexual Dysfunction Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue Share by Players (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Players in 2016
Figure Global Sexual Dysfunction Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Sexual Dysfunction Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Sexual Dysfunction Drugs Revenue Market Share in 2017
Figure Global Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Market Share by Regions in 2017
Figure North America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure South America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table North America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
Table North America Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure USA Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table Europe Sexual Dysfunction Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure Germany Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure UK Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure France Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Sexual Dysfunction Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure China Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure India Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table South America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
Table South America Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure Brazil Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Sexual Dysfunction Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue Share by Type (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Type (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Type in 2017
Table Global Sexual Dysfunction Drugs Revenue Forecast by Type (2018-2023)
Figure Global Sexual Dysfunction Drugs Market Share Forecast by Type (2018-2023)
Figure Global Oral Therapy Revenue Growth Rate (2013-2018)
Figure Global Intracavernosal Therapy Revenue Growth Rate (2013-2018)
Figure Global Hormonal Therapy Revenue Growth Rate (2013-2018)
Figure Global Transurethral Therapy Revenue Growth Rate (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue by Application (2013-2018)
Table Global Sexual Dysfunction Drugs Revenue Share by Application (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Application (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue Share by Application in 2017
Table Global Sexual Dysfunction Drugs Revenue Forecast by Application (2018-2023)
Figure Global Sexual Dysfunction Drugs Market Share Forecast by Application (2018-2023)
Figure Global Male Revenue Growth Rate (2013-2018)
Figure Global Female Revenue Growth Rate (2013-2018)
Figure Global Sexual Dysfunction Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Sexual Dysfunction Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Sexual Dysfunction Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
Figure Europe Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
Figure South America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
